Dr. Salvador González interview during the Asian Board
05:01 – The expert Dr. Salvador González talks in this interview about Fernblock, Heliocare´s main technology.
Neoretin Discrom Control: Depigmenting protocol of proven efficacy for all skin types and ethnicities by Cantabria Labs
The Journal of Clinical and Cosmetic Dermatology recently published an article which highlights how Neoretin Discrom Control helps to reduce...
Fernblock®, the main ingredient of Heliocare Oral, demonstrates its effectiveness against melasma
A new study has shown that Fernblock®, the main ingredient of Heliocare Oral and unique technology of Cantabria Labs, improves...
Susana Rodríguez, new CEO of Cantabria Labs
Susana Rodríguez Navarro has been appointed as CEO and Managing Director of the Spanish pharmaceutical company Cantabria Labs. The CEO...
Cantabria Labs is sponsoring “The Beautiful Brain” exhibition with works by Santiago Ramon y Cajal at the MIT
With the sponsorship of Cantabria Labs, the MIT (Massachusetts Institute of Technology) Museum is hosting “The Beautiful Brain”, the largest international exhibition...
A new study to test the efficacy of Endocare C Proteoglycans Oil-Free vials of Cantabria Labs
A new study published on January 16 in the Journal of Clinical and Cosmetic Dermatology (M Vitale et al, 2018)...
Cantabria Labs, the natural evolution of IFC
As of today, Cantabria Labs is the new corporate brand name which will represent IFC, Industrial Farmaceutica Cantabria. It symbolises...
IFC awards pioneering research in the diagnosis of Multiple Sclerosis at the “IDEA² Global Awards” of MIT
Within the framework of the 2nd edition of the “IDEA2 Global Awards” given by the prestigious Massachusetts Institute of Technology...
The planting of two trees marks the start of construction of the new Industrial Farmacéutica Cantabria centre
Industrial Farmacéutica Cantabria (IFC) starts construction in La Concha, in the municipal area of Villaescusa (Cantabria), of its new centre...